Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 881-900
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Josh Felker Co-Founder at Nascent | Montreal, Canada | Family OfficeVenture capital | AIConsumer | View profile | |
Ethan Shin Investor at Kb Investment | Cambridge, United States | Private equityVenture capital | AIClimate | View profile | |
Umesh Shanghvi angel investor | Mumbai, India | Angel | AIFinTech | View profile | |
Brandon Drew angel investor and operator angel | Smyrna, United States | AngelOperator angel | HardwareHealthcare | View profile | |
Jonathan Silverstein President and Co-Founder at The Silverstein Foundation for Parkinson's with GBA | New York, United States | Family OfficePrivate equity | AIHardware | View profile | |
Pranav Seshadri Investor at T.Rx Capital | United States | Venture capital | AICommerce | View profile | |
Florian Reinaud Investor at Redmile Group | Paris, France | Private equityVenture capital | Healthcare | View profile | |
John Ballantyne angel investor and operator angel | Fargo, United States | AngelOperator angel | Healthcare | View profile | |
Dan Cowell angel investor and operator angel | Cambridge, United Kingdom | AngelOperator angel | Healthcare | View profile | |
Dan Vaughn angel investor and operator angel | Encinitas, United States | AngelOperator angel | AIHealthcare | View profile | |
Spencer Chandlee Investor at Cardinal Partners | New York, United States | Venture capitalVenture debt | FinTechHealthcare | View profile | |
Sabina Sperisen Investor at Lichtsteiner Foundation | Switzerland | Family Office | Healthcare | View profile | |
Amine Marouf Expert at Eit Health | Paris, France | Accelerator | AIHealthcare | View profile | |
Michael Liang Investor at InVivium Capital | Chicago, United States | Private equityVenture capital | AIClimate | View profile | |
Sanne Weijzen Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca | Hilversum, Netherlands | Corporate VC | Healthcare | View profile | |
David Schenkein Board Member at Regeneron | Boston, United States | Corporate VCVenture capital | AICommerce | View profile | |
Neil Wolff General Partner at VIVE Venture Capital | San Francisco, United States | Private equityVenture capital | AIClimate | View profile | |
Brian Baynes Founder at Petri | Boston, United States | Venture capital | AIFinTech | View profile | |
Deborah Buresh Jackson Founder at Plum Alley | New York, United States | Syndicate / Angel groupVenture capital | AIClimate | View profile | |
Louis Scaramanga Affiliated at Reference Capital | Geneva, Switzerland | Family OfficeFund of funds | AIEducation | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
